← Search & browse all drugs
RESPIRATORY SYSTEM › OTHER RESPIRATORY SYSTEM PRODUCTS › OTHER RESPIRATORY SYSTEM PRODUCTS › Lung surfactants
combinations
R07AA30
Forms & Strengths
- Inhalation solution: various fixed-dose combinations of surfactants and/or respiratory stimulants
- Metered-dose inhaler (MDI): various combinations of bronchodilators and anti-inflammatories
- Dry powder inhaler (DPI): combination formulations for respiratory conditions
Adult Dosing
- Dosage varies significantly depending on the specific active pharmaceutical ingredients in the combination
- Refer to individual agent monographs for precise dosing regimens
- Typically administered via inhalation 1 to 4 times daily as prescribed for specific indications
Pediatric Dosing
- Dosing depends on the specific combination product and patient age/weight
- Many combinations lack established safety and efficacy in pediatric populations
- Consult specific product labeling for age-appropriate dosing guidelines
Indications
- Management of respiratory distress syndrome in premature infants (surfactant combinations)
- Maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD)
- Resuscitation of neonates with respiratory depression
Mechanism of Action
- Multimodal action combining the pharmacodynamics of each constituent drug
- Surfactant combinations reduce surface tension at the air-liquid interface in the alveoli
- Bronchodilator and anti-inflammatory combinations relax airway smooth muscle and reduce inflammation
Contraindications
- Hypersensitivity to any active substance or excipient in the specific combination product
- Specific contraindications depend on the individual components of the formulation
Adverse Reactions
- Transient bradycardia or oxygen desaturation during administration (surfactant formulations)
- Local irritation, oral candidiasis, and hoarseness (inhaled corticosteroid combinations)
- Tremor, palpitations, and headache (beta-agonist combinations)
Drug Interactions
- Interactions depend heavily on the specific active ingredients comprising the combination
- Potential for additive pharmacodynamic effects with other central nervous system or respiratory agents
- Consult comprehensive drug interaction databases for specific combination products
Curated Content: Needs Vetting Before Put to Clinical Use